USPTO to Host Combined Medical Device & Biotechnology Partnership Meeting

Tuesday, January 29, 2012
8:30 AM to 3:45 PM

United States Patent and Trademark Office
Alexandria, Virginia

Madison Auditorium
600 Dulany Street, Alexandria, VA


The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.

For information of future meetings and presentations, please go to

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email to decline or confirm your attendance by August 31, 2012.


Washington - The U.S. Department of Commerce's United States Patent and Trademark Office (USPTO) will host a Medical Device Technology Partnership Meeting on Tuesday, January 29, 2013 designed to bring the medical device and biotechnology stakeholders together to share ideas, experiences and insights on best practices and provide a forum for discussion on how the USPTO can improve and expand its relationship with medical device technology stakeholders. The meeting, sponsored by Technology Centers 3700 and 1600, will include discussions on the Leahy-Smith America Invents Act (AIA), the Cooperative Patent Classification (CPC) system, and 101 subject matter eligibility.

What: Combined Medical Device & Biotechnology Partnership Meeting

When: January 29, 2013 at 8:30 a.m. - 3:45 p.m. EDT

Where: USPTO Campus, Madison North Auditorium
600 Dulany Street
Alexandria, VA 22314

Rick Seidel
, Assistant Deputy Commissioner for Patents, Mechanical Disciplines
Jackie Stone, Assistant Deputy Commissioner for Patents, Biotechnology Disciplines
Angela Sykes, Group Director TC 3700
Donald Hajec, Group Director TC 3700
Andrew Wang, Group Director TC 3700
Wanda Walker, Group Director TC1600
Janet Andres, Acting Group Director TC 1600

Space is limited and registration will be done on a first-come first-served basis. To RSVP, please visit the Combined Medical Device & Biotechnology Partnership Meeting registration page.


8:30-9:00 - Sign-In

9-9:30 - Intro

9:30-10:30 - CPC

10:45-11:45 - 101

1:00-2:00 - AIA Update

2:15-3:45 - Open round table discussion